THERAMETRICS - Trademark Details
Status: 709 - Registration cancelled because registrant did not file an acceptable declaration under Section 71
Serial Number
79142915
Registration Number
4654772
Word Mark
THERAMETRICS
Status
709 - Registration cancelled because registrant did not file an acceptable declaration under Section 71
Status Date
2021-07-02
Filing Date
2013-11-22
Registration Number
4654772
Registration Date
2014-12-16
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s)
Typeset
Design Searches
261701, 261705, 261706, 270301 - Straight line(s), band(s) or bar(s). Horizontal line(s), band(s) or bar(s). Diagonal line(s), band(s) or bar(s). Geometric figures forming letters or numerals, including punctuation.
Published for Opposition Date
2014-09-30
Attorney Name
Law Office Assigned Location Code
L70
Employee Name
SNYDER, NELSON B
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Description of Mark
The mark consists of the stylized term "THERAMetrics" with three parallel diagonal lines appearing in front of the letter "M" in "THERAMetrics".
Goods and Services
Pharmaceutical products and preparations for the treatment of cardiovascular and respiratory diseases, pulmonary fibrosis, sarcoidosis, lung disease, viral diseases, and infectious diseases; chemical preparations for sanitary purposes for medicine; pharmaceutical products for the treatment of idiopathic pulmonary arterial hypertension, familial pulmonary arterial hypertension, scleroderma, lupus erythematosus associated pulmonary hypertension, congenital systemic-to-pulmonary shunts associated pulmonary hypertension, portal hypertension associated pulmonary hypertension, HIV infection associated pulmonary hypertension, drugs and toxins associated pulmonary hypertension, glycogen storage disease associated pulmonary hypertension, Gaucher disease associated pulmonary hypertension, hereditary hemorrhagic telangiectasia associated pulmonary hypertension, hemoglobinopathies associated pulmonary hypertension, myeloproliferative disorders associated pulmonary hypertension, pulmonary veno-occlusive disease associated pulmonary hypertension, pulmonary capillary hemangiomatosis associated pulmonary hypertension, persistent pulmonary hypertension of the newborn, left-sided atrial or ventricular heart disease associated pulmonary hypertension, left-sided valvular heart disease associated pulmonary hypertension, pulmonary hypertension associated with chronic obstructive pulmonary disease, pulmonary hypertension associated with interstitial lung diseases, pulmonary hypertension associated with sleep disordered-breathing, pulmonary hypertension associated with alveolar hypoventilation disorders, pulmonary hypertension associated with chronic exposure to high altitude, pulmonary hypertension associated with developmental abnormalities, pulmonary hypertension due to chronic thrombotic and embolic diseases, pulmonary embolism due to tumor, parasites, foreign material, pulmonary hypertension associated with in situ thrombosis, pulmonary hypertension associated with sarcoidosis, pulmonary hypertension associated with histiocytosis X, pulmonary hypertension associated with lymphangiomatosis, pulmonary hypertension associated with sickle-cell disease, Eisenmenger syndrome, chronic fatigue syndrome, bronchial asthma, rheumatoid arthritis, lupus, Goodpasture's syndrome, Wegener's granulomatosis, type 1 diabetes mellitus, Hashimoto's thyroiditis, Grave's disease, multiple sclerosis, Guillain-Barre syndrome, Addison's disease, acute disseminated encephalomyelitis, antiphospholipid antibody syndrome, aplastic anemia, myasthenia gravis, opsoclonus myoclonus syndrome, optic neuritis, Ord's thyroiditis, acute respiratory distress syndrome, acute lung injury, Hamman-Rich syndrome, idiopathic pulmonary fibrosis, bronchiolitis obliterans, hypersensitivity pneumonitis, lymphangiomyomatosis (LAM), usual interstitial pneumonia (UIP), Von Gierke syndrome, Osler-Weber-Rendu-Syndrome, small cell lung carcinoma, cystic fibrosis, tuberculosis, Hepatitis B virus infections, psoriasis, allergic dermatitis, scar keloids, pyogenic granulomas, blistering disease, Kaposi sarcoma in AIDS patients, systemic sclerosis, persistent hyperplastic vitreous syndrome, diabetic retinopathy, retinopathy of prematurity, choroidal neovascularization, inflammatory bowel disease, periodontal disease, ascites, peritoneal adhesions, endometriosis, uterine bleeding, ovarian cysts, ovarian hyperstimulation, osteomyelitis, osteophyte formation, HIV-induced bone marrow angiogenesis, early diabetic nephropathy, cancer and malignancies and their metastases in numerous organs, hemangiomas, vasculitis, Sjögren's disease, DiGeorge syndrome, hereditary haemorrhagic telangiectasia, cavernous hemangioma, cutaneous hemangioma, lymphatic malformations, transplant arteriopathy, vascular anastomoses, adipose tissue in obesity, chronic allograft rejections; chemical preparations intended for healing, health care or medical and veterinary purposes, namely, chemical preparations for treating inflammatory, cardiovascular and respiratory diseases, pulmonary fibrosis, sarcoidosis, lung disease, viral diseases, and infectious diseases; chemical reagents for medical or veterinary purposes; diagnostic preparations for medical purposes; radiological contrast substances for medical purposes; detergents for medical purposes; medicated mouth care and treatment preparations; medicated skin care preparations
Goods and Services
Scientific research to order; conducting of research and development in the medical, pharmaceutical, pharmacological, biochemical and/or medical technology fields for others; conducting to order clinical studies and tests, namely, conducting clinical trials for others; assessment to order of scientific projects, namely, conducting scientific feasibility studies; scientific research consulting in the nature of evaluation to order of clinical studies and experiments; providing technical advice relating to operation of computers; providing scientific cooperations in the nature of providing scientific information in the field of pharmaceutical research; conducting scientific research projects in the medical, pharmaceutical, pharmacological, biochemical, and/or medical technology fields for others; scientific analysis laboratories
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
F - Section 71 - Cancelled
Class Status Date
2021-07-02
Primary Code
005
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
F - Section 71 - Cancelled
Class Status Date
2021-07-02
Primary Code
042
Correspondences
Name
Steven A. Abreu
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1193030
International Registration Date
2013-11-22
International Publication Date
2014-02-20
International Renewal Date
2023-11-22
Auto Protection Date
2015-08-20
International Status
001 - Request for extension of protection established
International Status Date
2014-02-21
Priority Claimed In
True
Priority Claimed Date
2013-06-13
First Refusal In
True
Trademark Events
Event Date | Event Description |
2014-02-21 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
2014-02-25 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2014-03-01 | APPLICATION FILING RECEIPT MAILED |
2014-03-10 | ASSIGNED TO EXAMINER |
2014-03-13 | NON-FINAL ACTION WRITTEN |
2014-03-14 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
2014-03-14 | REFUSAL PROCESSED BY MPU |
2014-03-14 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
2014-04-04 | REFUSAL PROCESSED BY IB |
2014-05-23 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2014-06-05 | ASSIGNED TO LIE |
2014-06-10 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2014-06-10 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2014-07-03 | FINAL REFUSAL WRITTEN |
2014-07-03 | FINAL REFUSAL E-MAILED |
2014-07-03 | NOTIFICATION OF FINAL REFUSAL EMAILED |
2014-08-20 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
2014-08-20 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2014-08-21 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2014-08-22 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2014-08-27 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
2014-09-10 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2014-09-30 | PUBLISHED FOR OPPOSITION |
2014-09-30 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2014-12-16 | REGISTERED-PRINCIPAL REGISTER |
2015-03-16 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
2015-05-08 | FINAL DISPOSITION PROCESSED |
2015-05-08 | FINAL DISPOSITION NOTICE SENT TO IB |
2015-06-12 | FINAL DECISION TRANSACTION PROCESSED BY IB |
2019-12-16 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
2020-02-10 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2021-07-02 | CANCELLED SECTION 71 |